Viking Therapeutics, Inc. (VKTX): Debt Offering News

VKTX – Files for $450 mln mixed securities shelf offering.


Key Facts Surrounding This News Item


  • VKTX had a POWR Rating of C (Neutral) coming into today.
  • VKTX was -3.15% below its 10-Day Moving Average coming into today.
  • VKTX was -9.73% below its 20-Day Moving Average coming into today.
  • VKTX was 22.54% above its 50-Day Moving Average coming into today.
  • VKTX was 47.27% above its 100-Day Moving Average coming into today.
  • VKTX was 90.88% above its 200-Day Moving Average coming into today.
  • VKTX had returned +138.92% year-to-date leading up to today’s news, versus a +5.40% return from the benchmark S&P 500 during the same period.

More Info About Viking Therapeutics, Inc. (VKTX)


Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead clinical program, VK5211, is an orally available, non-steroidal selective androgen receptor modulator in Phase II development for the treatment of patients recovering from non-elective hip fracture surgery; in Phase I clinical trials for improving lean body mass; and in pre-clinical trial for improving bone mineral density, bone mineral content, bone strength, and other measures. The company is also developing VK2809, an orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta, which is in a Phase II clinical trial for the treatment of patients with hypercholesterolemia and fatty liver disease; and in a Phase I clinical trial to treat patients who suffer from glycogen storage disease type Ia. In addition, it is developing VK0214 for X-linked adrenoleukodystrophy, which is in pre-clinical stage. Viking Therapeutics, Inc. was founded in 2012 and is based in San Diego, California. View our full VKTX ticker page with ratings, news, and more.

Try StockNews.com Premium Today!


Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!

Sign Up Now

VKTX at a Glance

VKTX Current POWR Rating™
Overall POWR Rating™
VKTX Current Price $18.37 0.91%
More VKTX Ratings, Data, and News

VKTX Price Reaction

The day of this event (Jul. 11, 2018)
VKTX Closing Price$10.00 3.09%
VKTX Volume1,785,200
15.70% from avg
Leading up to this event
VKTX 1-mo return8.66%
After this event
VKTX 1-day return6.37%
VKTX 3-day return10.68%
VKTX 5-day return3.00%

VKTX Price Chart



More Viking Therapeutics, Inc. (VKTX) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All VKTX News
Page generated in 0.9966 seconds.